New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.

Shares of Chinese biotechnology company Nanjing Leads Biolabs surged in their Hong Kong debut after overwhelming demand from investors. Shares surged as much as 127% to 79.60 Hong Kong dollars, ...

The dollar gained against the yen after bouncing off a two-week low on Thursday, helped by some firm US economic data, while ...